NIH Launches Collaborative Program, Matches Researchers with Compounds to Explore New Treatments

May 11, 2012 | by

The National Institutes of Health recently unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients. NIH’s new National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly and Company which have agreed to make dozens of their compounds available for this initiative’s pilot phase.

NIH collaborative program

Drug Companies Collaborate to Fight Neglected Tropical Diseases

February 2, 2012 | by

A global initiative to fight neglected tropical diseases launched in London this week. The so-called London Declaration calls for the eradication of 10 neglected tropical diseases by 2020. Experts are calling it the largest coordinated effort ever undertaken to combat diseases that affect 1.4 billion people in the world’s poorest countries.

Tropical disease